Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
Profitability Metrics
Gross Margin
55.90%
Operating Margin
38.49%
Net Margin
32.70%
Efficiency Metrics
Revenue per Expense Ratio
1.63
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
59.69%
Income Tax Rate
16.98%
EPS
20.9500000000
Balance Sheet Analysis
Current Ratio
2.61
Cash Ratio
2.03
Working Capital
$1.01B
Debt to Equity
0.71
Debt to Assets
28.01%
Equity Ratio
39.60%
Cash Flow Analysis
Operating Cash Flow Ratio
42.49%
Free Cash Flow Ratio
41.88%
CapEx to Revenue
0.60%
Dividends Paid
$1.50M
Stock Buybacks
$341.90M
Total Shareholder Returns
$343.40M
Cash Position Change
89.56%
Key Takeaways (2023 FY)
Revenue declined by 11.667239010989%, indicating potential market challenges
Increased dividend payments by 2.83%
Detailed Growth Metrics
Core Performance
Revenue
-11.67%
Net Income
-41.28%
EPS
-29.60%
Operating Income
-54.75%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
-7.08%
Operating Cash Flow
-17.10%
Free Cash Flow
-17.39%
Balance Sheet Health
Assets
2.01%
Debt
0.09%
Book Value per Share
17.31%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
2.83%
Shares Outstanding
-8.83%
Long Term Trends
3Y Revenue/Share
34.46%
5Y Revenue/Share
32.12%
3Y Dividend/Share
-88.17%
5Y Dividend/Share
-96.44%